Aging muscles lose more than mass
Skeletal muscle is one of the first tissues to show clear decline with age, and the effects reach beyond reduced strength. Older muscle can accumulate scar tissue and fat, lose fast-twitch fibers used for quick and forceful movement, and recover less effectively after strain or injury. A study reported by Kyushu University describes a possible way to intervene earlier in that process by protecting one of the molecular signals that tells muscle stem cells to wake up and begin repair.
The work focuses on hepatocyte growth factor, or HGF, a protein with a central role in muscle regeneration. In healthy skeletal muscle, HGF remains stored in the supportive matrix around muscle fibers. When muscle is injured or mechanically stimulated, the protein is released and binds to c-Met receptors on satellite cells, the stem cells that help rebuild damaged tissue. That binding activates the cells, allowing them to proliferate, differentiate, and contribute to repair.
The problem, according to the research team led by professor Ryuichi Tatsumi, is that aging can disrupt that system without necessarily removing HGF from the tissue. Earlier work by the group found that HGF can undergo nitration, a chemical modification in which a nitro group is added to two sites on the protein, Y198 and Y250. Those sites sit in the region HGF uses to bind to c-Met. Once altered, the protein loses much of its ability to dock with the receptor, undermining the signal that normally starts muscle regeneration.
Turning damaged HGF into “Super HGF”
Rather than trying to replace the protein, the researchers tested whether sulfur-containing compounds could remodel it into a more active form. Their experiments identified one candidate, lipoic acid trisulfide, abbreviated LASSS, that interacted with HGF in a way the team says enhanced the protein’s receptor-binding ability while also making it more resistant to the dysfunction caused by nitration.
The researchers describe the remodeled molecule as “Super HGF,” a version of the protein with stronger affinity for c-Met. The proposed mechanism centers on the protein’s disulfide bonds. By converting some of those bonds into trisulfide bonds, LASSS appears to alter the structure of HGF enough to improve its performance. In practical terms, that means the same repair signal that weakens with age may be reinforced instead of replaced.
That distinction matters. Age-related muscle loss, including the broader problem of declining regenerative capacity, is difficult to address because it involves many overlapping biological changes. A treatment that restores function to an existing repair pathway could be easier to integrate into future therapies than one requiring wholesale replacement of damaged tissue or repeated external stimulation.
Why the finding stands out
The study is notable because it targets a bottleneck in the muscle-repair process. Satellite cells cannot contribute effectively if they are not activated in the first place. HGF serves as one of the body’s early alerts, and the Kyushu team’s earlier research suggests that aging leaves that alarm system partially intact but chemically impaired. If that interpretation holds, then reversing or bypassing the impairment could help preserve function before muscle decline becomes severe.
The report also points to a broader principle in aging biology: deterioration does not always mean a signal disappears. Sometimes the machinery is still present but less able to interact with the receptors or structures it depends on. By showing that a sulfur-based compound may restore that interaction, the study offers a narrower and potentially more controllable therapeutic concept than some age-reversal narratives that promise systemic rejuvenation.
Another reason the finding draws interest is the potential relevance beyond humans. The source report notes that the work could eventually inform treatments for age-related muscle loss in companion animals as well. That does not mean a therapy is close, but it does suggest the underlying biology may be useful across species that experience similar muscular decline.
What this does and does not show
The results are promising, but they should be read as an early-stage research development rather than a near-term clinical breakthrough. The source text supports the conclusion that LASSS strengthened HGF function and improved resistance to age-related chemical damage. It does not establish that a finished therapy exists, that it is proven safe in humans, or that it can reverse sarcopenia in real-world patients.
That gap is important because muscle aging is not driven by a single factor. Hormonal shifts, inflammation, reduced activity, nerve changes, nutrition, and broader metabolic stress all shape how muscle weakens over time. Even if HGF restoration proves useful, it would likely form one part of a more complex treatment strategy.
Still, the study adds a concrete mechanistic target to a field that often struggles to connect molecular findings with functional decline. Instead of speaking in general terms about “healthy aging,” the work identifies a specific protein, the specific sites where it is altered, and a specific compound that may counter that loss of function. That makes the result easier to test, challenge, and build on.
The next step for muscle-loss research
The immediate significance of the study lies in its precision. Age-related muscle wasting is a major quality-of-life issue because it affects independence, balance, recovery from illness, and susceptibility to injury. Interventions that preserve fast-twitch fibers and repair capacity could have outsized benefits for mobility and resilience in older adults.
For now, the new result is best understood as a promising laboratory advance: a demonstration that a key muscle-repair signal can potentially be upgraded rather than abandoned as it ages. If future work confirms that the effect translates into stronger regeneration in living organisms and can be delivered safely, it may open a new path for therapies aimed at keeping muscle stronger for longer.
This article is based on reporting by Medical Xpress. Read the original article.
Originally published on medicalxpress.com
